The nature of the response to both hGH and AOD9604 is not clearly understood. We hypothesized that both molecules may influence the expression of the β3-adrenergic receptors (β3-ARs), the major lipolytic receptor in fat tissue. Both AOD9604 and hGH can increase β3-AR mRNA expression, as well as protein levels and function, in mouse and human cell lines in vitro (11). This response was investigated at the level of RNA and protein expression and function. The results for each mode of analysis were consistent in that both hGH and AOD9604 acted in a dose- and time-dependent manner to modulate the β3-AR response.
If you want to lose weight you’re going to need to keep track of your calories. Don’t just estimate portion sizes – at least in the beginning. You’ll probably be amazed at how little the serving sizes are for many of your favorite foods. You could easily add hundreds of calories to your daily intake by estimating measurements, which can derail your weight loss results. Use a fitness app or calorie tracker to help you stay on track. Some favorites include:
17 Arora P, Wu C, Khan AM, Bloch DB, Davis‐Dusenbery BN, Ghorbani A, Spagnolli E, Martinez A, Ryan A, Tainsh LT, Kim S, Rong J, Huan T, Freedman JE, Levy D, Miller KK, Hata A, Del Monte F, Vandenwijngaert S, Swinnen M, Janssens S, Holmes TM, Buys ES, Bloch KD, Newton‐Cheh C, Wang TJ. Atrial natriuretic peptide is negatively regulated by microrna‐425. J Clin Invest. 2013;123:3378–3382.CrossrefMedlineGoogle Scholar
Acromegaly is characterized by an excessive amount of articular cartilage in joints caused by excess GH secretion [25]. The tremendously thick articular cartilage in acromegaly can be explained by the local production of IGF-1 in cartilage cells through GH receptors [9,18]. Long-term treatment with GH might induce hypertrophy of the cartilage and changes in the joint geometry because of altered subchondral bone structures. Long-term treatment with GH by local injections may also be associated with various risks, including glucose intolerance, insulin resistance, diabetes, cancer, edema, and hypertension [26–29]. AOD9604 is not an agonist with a high affinity to the GH receptor and does not stimulate the production of IGF-1. Therefore, AOD9604 may be safer than human recombinant GH for the long-term treatment of OA.
Time line of collagenase, saline, HA and AOD9604 injection. Collagenase (0.25 mg) was injected in right knee twice on day 1 and 4, respectively. Normal saline 0.6 ml (group 1), HA 6 mg (group 2), AOD9604 0.25 mg (group 3), and AOD9604 0.25mg with HA 6 mg (group 4) were injected in the right knee at 4 weeks after the first collagenase injection. All rabbits were euthanized by CO inhalation at 4 weeks after injection of 4 different solutions.
•Avoid eating/drinking anything with calories for three (3) hours either side of your injection. •Try to make all your meals throughout the day high protein, low fat and low carbohydrates (eg. meat/fish with vegetables/salad). •Have as few meals as possible during the day as periods of fasting have been shown in many studies to improve fat loss and also longevity (i.e. eating less will make you live longer).
An important component of losing weight and staying healthy is being active-whether by going to the gym or even just walking regularly. To stay active, we need to make sure our bodies stay strong, as well as avoid injuries or other aches and pains that may prevent us from working out. Collagen supplementation can help. Adding collagen protein into your daily diet can help support your bones and joints. In a 24-week study, researchers observed the effect of collagen hydrolysate supplementation on exercise related joint pain on 97 human athletes. The researchers found that collagen supplementation can reduce joint pain (3). Therefore, adding collagen into your daily routine can help in your weight loss plan by preventing pain and joint injury arising from physical activity and exercise.

AOD9604, a synthetic fragment of hGH consisting of the amino acid residues 177–191 with the addition of a tyrosine residue to the N-terminus was prepared with solid-phase synthesis procedure and purified with reverse-phase HPLC methodology in our laboratories (13). The structure of the peptide analog was verified with mass spectrometry and amino acid analysis. The hGH was a gift of Professor Michael Waters (University of Queensland, Brisbane, Australia). BRL37344 (β3-AR agonist) was a gift from Dr. Jon Arch (SmithKline Beecham, Harlow, UK).


As both CJC1295 and Ipamorelin bind to the pituitary gland and prompt the release of GH, when used together, the production of growth hormone is over 10 times more than when used individually. As it stimulates the body’s natural growth hormone production it also causes the release of IGF-1. The advantages of the CJC peptide is that it helps increases bone density and collagen, as well as boosting the immune system. It will also produce new muscle cells which will be leaner and increases weight loss. The CJC 1295 results are part of years of scientific studies. It primarily increases the production of proteins, which leads to stable bodily functions related to the glands in the body or the endocrine system.

The most potent weight loss peptide is HGH Fragment 176-191 which is the part of the Growth Hormone molecule responsible for fat burning. In HGH Frag Studies, it has been proven to reduce body fat, particularly in the abdominal area. The second most potent fat loss peptide is CJC-1295 DAC since it causes the overall GH level to rise in the body (the opposite of what happens naturally as a person gets older, which is why people tend to put on weight as they age). If your only goal is fat loss, it's often best to avoid the use of GHRP products (GHRP-6, GHRP-2 or Ipamorelin) since they can stimulate hunger and/or raise cortisol, both of which can be counterproductive to fat burning.
Peptides are a generic name given to any group of amino acids that are linked together to form a chain. Essentially, they are similar to proteins, though in much shorter lengths (less than 50 units long). In the world of bodybuilding and exercise science, peptides generally refer to one of two things. They can refer to either broken protein fragments from hydrolysed proteins, or peptide hormones and related compounds.

Metabolic has just completed Phase IIA studies in a group of 22 clinically obese, but otherwise healthy, male patients ranging in age from 22?50. The results showed that the drug was well tolerated and increased fat metabolism within two hours of administration by 25 per cent in the older group of patients. Although not the focus of the study, weight loss was also demonstrated, particularly in the older group.
Actually, it's under S0 because it is not approved for human use by any regulating authority anywhere. The S2 category is the one relating to mimicking effects of other compounds or GH. But you were right, the OP is fundamentally incorrect. The real reasons that Dank chose this compound to administer to Essendon players is still a mystery but we can be certain it wasn't paid for or administered for the fun of it.
Prof. Louis J Aronne MD, President of the North American Association for the Study of Obesity and a member of Metabolic’s Clinical Advisory Panel, said: "This is an exciting new approach to a problem which has defied easy solutions. We will need many different treatments if we are going to manage obesity successfully, in much the same way we have many treatments available for diabetes and hypertension".

Best deal I found searching around. I plan to read up on datbtrue's forum once I get accepted. Right now I'm thinking wake up, and inject 500mcg, shower, hit the gym, leave do cardio, then eat. At night before bed inject another 500mcg. Not set in stone yet as I need to read up more, but this is what I'm thinking. Currently running cjc 1295 no dac, ghrp-2, and igf-1 LR3, Hup-a, and green tea extract.

Metabolic turned their attention to human studies and performed six clinical trials on 925 people between 2001 and 2007. Not one of these trials showed that AOD9604 caused any weight loss or changes in body composition (3). In 2007, the company that owns Metabolic, Calzada, reported to their shareholders that AOD9604 showed no promise, and was being abandoned as a weight loss drug (2,3). The failure was blamed on inefficient absorption of the peptide drug through oral administration, as was used in the trials, even though rodent studies had shown the oral delivery route to be effective. At this point, Metabolic had sunk a massive $50 million into development and trials of AOD9604.

Osteoarthritis (OA) is a degenerative joint disease that results from articular cartilage loss induced by complex interactions of genetic, metabolic, biochemical, and biomechanical factors with secondary components of inflammation [1]. OA is the most common arthritis and a major medical problem in people aged 65 years and older [2]. Non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, exercises, corticosteroids, and hyaluronic acid injections have all been used for the conservative treatment of OA. The role of NSAIDs in OA management is controversial because of its adverse side effects, as well as side effects on the cartilage [3].
We identified 34 patients who met eligibility criteria based on the chart review. Two subjects were excluded because they were found to have diabetes requiring insulin therapy, 1 was excluded because of hypothyroidism, and 13 were excluded because they did not undergo gastric bypass surgery or did not wish to participate. A final study sample of 18 individuals (15 women) was enrolled into the protocol. We had 3 individuals who did not complete the 6‐month follow‐up visit; the sample that completed both visits consisted of 15 individuals (12 women). No subjects were excluded because of peri‐operative complications. Table 1 displays the characteristics of the study sample at baseline and 6 months after surgery. From baseline to 6 months after surgery, subjects had a mean decrease of 27% in body mass index (P<0.0001). There were significant reductions in mean arterial blood pressure (P=0.004) and heart rate (P<0.001) after surgery. Only 2 out of 18 subjects were on any class of anti‐hypertensive medications at the pre‐op visit before gastric bypass surgery. At the 6‐month visit, anti‐hypertensive medication was discontinued for one of these subjects, and continued at the same dose for the other subject. The mean±SD volume of saline infusion pre‐bypass was 2.6±0.4 L and post‐bypass was 2.3±0.3 L.
The first reason is that CJC-1295 DAC is a GHRH (growth hormone releasing hormone) acting directly at the pituitary, while GHRP products indirectly stimulate GH by causing the release of Ghrelin. Rotating the products would therefore ensure one method of GH stimulation does not get "worn out" from repeated exposure to the peptides. The second reason is that even though CJC-1295 DAC has been proven safe in much higher dosages than we recommend, since it causes a continual GH release (GH bleed) no one can be certain how continual use would affect the pituitary in the long-term, so it's a case of being "better safe than sorry" and never using it for longer than 6 months at a time without a break.
The acute effect of AOD9604 and BRL37344 (aβ 3-AR agonist) on energy expenditure and substrate oxidation rates in WT and KO mice was also assessed. KO animals had lower energy expenditure, lower fat oxidation, and increased glucose oxidation, compared with the WT controls (data not shown). Injection of WT mice with a single dose of BRL37344 or AOD9604 increased energy expenditure and fat oxidation and decreased glucose oxidation. In the KO animals, BRL37344 failed to elicit any response in these metabolic parameters, clearly demonstrating that its effects are mediated exclusively through the β3-AR. AOD9604 did elicit a response in the KO mice, increasing fat oxidation and energy expenditure, although the response was not as great as in WT mice, suggesting that β3-ARs are not responsible for the acute biological response of AOD9604 on lipid metabolism. This is consistent with our previous findings in which AOD9604 was shown not to bind to the β3-AR (11). The size and duration of the metabolic responses to AOD9604 in the β3-AR KO animals was different from that observed in the control wild-type mice. The response was more rapid, shorter in duration, and greater in peak response. This may be because the KO animals are more acutely sensitive to lipolytic agents, a compensation for the ablation of the major lipolytic receptor.
I’m 50 and have been using CJC-1295+Ipamorelin Combo for almost 1 year now. Yes with 2 rest periods. Very very happy with the results. Skin is smoother / softer to touch reduced bags under my eyes, my wife loves the new feel. I train 5 days a week and the increase in muscle volume and tone is very noticeable. I will say however it is a slow steady natural looking increase. Recovery is great and I think it is helping with injury repair, as i have a problem Knee that is feeling alot better ever since I’ve been on this product. As you can see the cost is high but if there were no outstanding results my wife would say I was a Di#*head, but she is encouraging me to continue. Train hard, eat well and look better. Use CJC-1295+Ipamorelin Combo. I do
Statistical analysis was performed using SPSS version 14.0 (SPSS, Chicago, Ill). The differences of gross morphological and histolopathological findings and lameness period among four groups were assessed using the Kruskal–Wallis test. The Mann–Whitney U test was used to compare the gross morphological and histolopathological findings and lameness period between two groups, and p-values <0.05 were considered statistically significant.

However, using a credit card, Crikey was able to easily order a 5 milligram vial of GHRP-6 without a permit or a prescription from the US-based Peptide Labs for the the bargain-basement price of $US18.50 plus $US10 postage and handling. A disclaimer attached to the sale stresses the peptide is "not for human use" and is for "LABORATORY USE ONLY". At 99% purity, the peptide boasts "paramount attributes for experiments involving muscle synthesis and recovery". Delivery is promised between 7-14 days after the payment is processed.
To get the best results from your fat loss program and the highest fat loss amount from CJC 1295 Ipamorelin peptide supplementation, it is important to follow a diet that is rich in protein, low in carbs, moderate in the health fats while being physically active and doing cardio exercise as often as you can. Also, you need to keep your hormone levels properly balanced in order to boost your metabolism.
“We are delighted with these results,” stated Metabolic Pharmaceuticals CEO, Chris Belyea. “The evidence from the trial is that over 12 weeks AOD9604 induces competitive weight loss with accompanying health benefits at a low dose and has superior tolerability. Our next major focus is a partnership with a major pharmaceutical company to assist in financing late stage longer term human clinical trials for worldwide marketing approval as a prescription treatment.”

From this study it appears that the β3-AR is an important contributor to the effects observed on body weight in obese mice treated with AOD9604 and hGH. To determine whether theβ 3-AR is partly responsible for this effect, we examined the effects of AOD9604 and hGH in theβ 3-KO mouse. The β3-KO mouse is not grossly obese, but female mice have increased fat depots (21) and the mice do develop late-onset obesity (Summers, R. J., personal communication). AOD9604 and hGH increased body mass and decreased BAT mass in the WT strain but had no effect in the KO animals. In WT mice, plasma glycerol was increased in response to AOD9604 and hGH treatment (4 wk). However, in the KO mice, only hGH resulted in increased levels of glycerol in the KO mice, and this effect was significantly less than that observed in the WT mice. This suggests that the regulation of the β3-AR is essential in the ability of AOD9604 and hGH to mediate chronic effects on lipolysis and fat mass reduction.
Aging often comes with many undesirable effects on our bodies including increased fat, decreased muscle muscle mass and low energy.  Some of these issues can be caused by adult growth hormone deficiency.  Peptide therapies provide a healthy option to reinvigorate the natural release of growth hormone in the body and reverse the negative effects of aging.
In lean animals, neither AOD9604 nor hGH had any effect on epididymal white adipose tissue mass or expression ofβ 3-AR RNA, indicating that in lean animals, this fat tissue is not a major target for these drugs in this study. In contrast, the mass of BAT in lean animals was reduced by both hGH and AOD9604, and β3-AR RNA expression was increased by both these compounds. This could possibly suggest that the increased expression of β3-ARs in brown adipocytes sensitizes catecholamines to dissipate heat.
Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the GH molecule. This region, which consists of amino acids 177-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance. It works by mimicking the way natural Growth Hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified Growth Hormone.
Improved glucose metabolism after RYGB and sleeve gastrectomy involves several mechanisms: early increased hepatic insulin sensitivity, resulting from reduced liver fat content in response to the postoperative caloric restriction, improved beta-cell function mediated by exaggerated postprandial GLP-1 secretion; as demonstrated by relapse of impaired glucose tolerance in studies blocking the GLP-1 receptor by exendin 9–39, and later after major weight loss increased peripheral insulin sensitivity. Gut hormone secretion changes towards a more anorectic profile and is likely important for less caloric intake and weight loss.
In this paper, we investigated whether the changes observed inβ 3-AR RNA expression in vitro also occur in an in vivo model. The in vivo model used was the obese (ob/ob) mouse model of obesity that has repressed levels of β3-ARs, which in part contributes to reduced lipolytic sensitivity (12). Lean C57BL/6J mice were used as a control. Following a 14-d chronic administration with AOD9604 or hGH, adipose tissue weights were measured, and β3-AR mRNA expression was determined. The decrease in weight of adipose tissue depots in the ob/ob mice was associated with increasedβ 3-AR expression. Further studies inβ 3-AR knock-out (β3-KO) mice showed that the presence of the β3-AR is necessary to mediate the chronic effectiveness of hGH and AOD9604 with regards to weight loss and fat mass reduction. However, an acute dose of AOD9604 was capable of increasing energy expenditure inβ 3-KO mice, although the response was less than that seen in the wild-type control mice.
Peptide therapy, or the use of specific peptides in treatment, has gained great popularity in recent years. This is due largely to the fact that these peptides are highly specific (i.e., only do what you want them to do) while also being well-tolerated and safe. As of January 2015, there were over 60 US FDA-approved peptide medications, 140 peptide drugs being evaluated in clinical trials, and 500 in pre-clinical development.

Collagen is also supposed to help with joint pain. Although I (luckily) don’t have chronic pain in my joints, my knees do flare up from time to time ever since I ran a half marathon a couple years ago. I also get some soreness in what feels like the bones in my legs a couple times a week, usually after a run or intense cardio session. If drinking collagen would ease this pain, then I was game.
The rabbits were clinically observed daily at 14:00. The rabbits were placed on a 2-m2 ground area, and gait was individually assessed by direct observation for 20 minutes. The knee and ankle of the intact rabbit limb showed typical flexion and extension cycle during hopping. Lameness was defined as the inability to bear weight and the loss of typical flexion and extension cycle of the affected limb during hopping compared with that of the unaffected limb. The severity of lameness was not quantified. The time taken to return to normal ambulation without lameness of the affected limb was recorded for each group. The lameness period was checked by three independent physiatrists who did not have knowledge of the experimental groups.
Id do 150mc of ghrp2, 20min later 2-5iu of GH ( as much as you can afford) then be taking albuterol all day long with 25mcg of T3. Peptides fell off the map 1-2 yrs ago, all the good suppliers began to put of shit. Once upon a time you could get LR3 for under 100 bux............like legit stuff. igf DES was around for another year after LR3 went bunk with 95% of places.
Not every peptide will suite every individual and it may take some experimenting to get the right peptide and dose. Our recent article explains more about who peptides will work for. So what is the best peptide for fat loss and is there any one type that will almost guarantee some success? The answer is NO! Everyone is different and to repeat what was said above, experimenting is vital for success.
The lateral and medial condyles of the femur and tibia were fixed with 10% neutral buffered formalin and decalcified with 20% ethylenediaminetetraacetic acid (EDTA). Calcified condyles were embedded in paraffin, and standard frontal sections of 5 μm were prepared and stained with haematoxylin and eosin in the cartilage of the lateral part of the femoral condyle, according to gross morphological observations [14]. If the staining was not adequate, the specimen was cut at the next cartilage surface. Cartilage degradation features were analyzed using the scoring system modified by Mankin et al. [14]. Histopathological evidence of cartilage degeneration was evaluated by structural scoring (0, normal; 1, surface irregularities; 2, pannus and surface irregularities; 3, clefts to transitional zones; 4, clefts to radial zones; 5, clefts to calcified zones; and 6, complete disorganization) and cell status (0, normal; 1, diffuse hypercellularity; 2, cloning; and 3, hypocellularity) of the articular cartilage. Total score ranged from 0 (normal) to 9 (complete disorganization and hypocellularity of the articular cartilage). All sections were graded by two independent pathologists who did not have any information about the injection solutions.

The banned "peptide" believed to have been injected into numerous Australian professional athletes can be bought in under 30 seconds online. GHRP-6, the growth hormone-releasing peptide that features in the Australian Crime Commission's report into organised crime and drugs in sport released this morning, was identified -- alongside other so-called performance and image enhancing drugs (PIEDs) -- as a dubious supplement threatening to cast a pall over the country's professional codes. Although unproven, GHRP-6 purportedly helps the body repair damaged tissue and can stimulate human growth hormones to improve athletic performance. It can be used in conjunction with anabolic steroids to promote muscle gain. Peptides are classified as a prohibited substance on the World Anti-Doping Agency prohibited list and were banned for use both in and out of competition in 2008. The ACC report said most peptides are also:
×